Cargando…

The Level of Cholesterol in COPD Patients with Severe and Very Severe Stage of the Disease

BACKGROUND: High blood cholesterol is part of metabolic syndrome and can be caused by medical conditions or bad dietary habits. AIM: The aim of the study was to investigate the prevalence of hypercholesterolemia in privies diagnosed patients with the severe and very severe stage of COPD, which were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zafirova-Ivanovska, Beti, Stojkovikj, Jagoda, Dokikj, Dejan, Anastasova, Sasha, Debresliovska, Angela, Zejnel, Sead, Stojkovikj, Dragana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Institute of Immunobiology and Human Genetics 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908745/ https://www.ncbi.nlm.nih.gov/pubmed/27335600 http://dx.doi.org/10.3889/oamjms.2016.063

Ejemplares similares

The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
por: Stojkovikj, Jagoda, et al.
Publicado: (2016)

Goodpasture Syndrome Diagnosed One Year And A Half after the Appearance of the First Symptoms (Case Report)
por: Stojkovikj, Jagoda, et al.
Publicado: (2016)

Concurrent radiochemotherapy in locally-regionally advanced oropharyngeal squamous cell carcinoma: analysis of treatment results and prognostic factors
por: Krstevska, Valentina, et al.
Publicado: (2012)

Relationship between Vitamin D, Inflammation and Lung Function In Patients with Severe Uncontrolled Asthma
por: Janeva-Jovanovska, Elena, et al.
Publicado: (2017)

The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1
por: Janeva, Elena Jovanovska, et al.
Publicado: (2015)

Prevalence, Gender Distribution and Presence of Attention Deficit Hyperactivity Disorder by Certain Sociodemographic Characteristics Among University Students
por: Panevska, Lidija Sushevska, et al.
Publicado: (2014)

Relationship Between ADHD and Depression Among University Students in Macedonia
por: Panevska, Lidija Sushevska, et al.
Publicado: (2015)

Unintended cation crossover influences CO(2) reduction selectivity in Cu-based zero-gap electrolysers
por: El-Nagar, Gumaa A., et al.
Publicado: (2023)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland
por: Samyshkin, Yevgeniy, et al.
Publicado: (2013)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
por: Calverley, Peter M, et al.
Publicado: (2016)

Physiologic (18)F‐FDG muscle uptake in severe COPD: Implications for accurate lung cancer staging
por: Yoshida, Yuma, et al.
Publicado: (2023)

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD
por: Dong, Weigang, et al.
Publicado: (2018)

Comparative Spectroscopic Study Revealing Why the CO(2) Electroreduction Selectivity Switches from CO to HCOO(–) at Cu–Sn- and Cu–In-Based Catalysts
por: El-Nagar, Gumaa A., et al.
Publicado: (2022)

Stress Causing Factors Among Teachers in Elementary Schools and Their Relationship with Demographic and Job Characteristics
por: Agai–Demjaha, Teuta, et al.
Publicado: (2015)

Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and brochodilators for severe and very severe COPD patients
por: Negro, Roberto Dal, et al.
Publicado: (2007)

Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis
por: He, Wenqing, et al.
Publicado: (2023)

Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial
por: Chen, Yuanbin, et al.
Publicado: (2020)

Cardiac Troponin T and Illness Severity in the Very-Low-Birth-Weight Infant
por: Lopes, Danielle N., et al.
Publicado: (2012)

Serum Acylglycerols Inversely Associate with Muscle Oxidative Capacity in Severe COPD
por: LI, RONGSONG, et al.
Publicado: (2021)

Evaluation of Neonatal Hemolytic Jaundice: Clinical and Laboratory Parameters
por: Cherepnalkovski, Anet Papazovska, et al.
Publicado: (2015)

Multi-class/residue method for determination of veterinary drug residues, mycotoxins and pesticide in urine using LC-MS/MS technique
por: Hajrulai-Musliu, Zehra, et al.
Publicado: (2023)

Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
por: Mantero, Marco, et al.
Publicado: (2018)

Uric acid and left ventricular hypertrophy: another relationship in hemodialysis patients
por: Selim, Gjulsen, et al.
Publicado: (2019)

Comparison of disease-severity measures within severe and very severe COPD patients: results from a nationally representative chart review and patient survey
por: Solem, Caitlyn T, et al.
Publicado: (2014)

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
por: Andreas, Stefan, et al.
Publicado: (2020)

Alternative approach to autonomic instability of very severe tetanus: stellate ganglion block
por: Altıparmak, Başak, et al.
Publicado: (2016)

Study on the Optimal Surgical Scheme for Very Severe Osteoporotic Vertebral Compression Fractures
por: Wen, Zhenxing, et al.
Publicado: (2022)

Central arterial stiffness is increased among subjects with severe and very severe COPD: report from a population-based cohort study
por: Qvist, Linnea, et al.
Publicado: (2015)

Maximal respiratory static pressures in patients with different stages of COPD severity
por: Terzano, Claudio, et al.
Publicado: (2008)

Effect of joint mobilization and stretching on respiratory function and spinal movement in very severe COPD with thoracic kyphosis
por: Wang, Joong-San
Publicado: (2015)

Acute bronchodilator responses decline progressively over 4 years in patients with moderate to very severe COPD
por: Tashkin, Donald P, et al.
Publicado: (2014)

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies
por: Ferguson, Gary T., et al.
Publicado: (2020)

Cardiology clinic visit increases likelihood of evidence‐based cholesterol prescribing in severe hypercholesterolemia
por: Groth, Nicole A., et al.
Publicado: (2020)

Sarcopenia in COPD: relationship with COPD severity and prognosis
por: Costa, Tatiana Munhoz da Rocha Lemos, et al.
Publicado: (2015)

Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD
por: Hansen, Henrik, et al.
Publicado: (2018)

Inter-Day Test–Retest Reproducibility of the CAT, CCQ, HADS and EQ-5D-3L in Patients with Severe and Very Severe COPD
por: Hansen, Henrik, et al.
Publicado: (2021)

Effects of Empirical Glucocorticoid Use on Severe Acute Exacerbation of COPD During Hospitalization
por: Wu, Ling, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD)
por: He, Yuanzhou, et al.
Publicado: (2020)

Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model
por: Wilson, Michele R, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gh1ouhcu53n7mgbl1ephhbte9j